Category : Search result: pharmaceutical safety investigation


Nvidia, Eli Lilly Launch $1B AI Drug Discovery Lab

Nvidia commits $1 billion to a joint AI laboratory with pharmaceutical giant Eli Lilly, aiming to automate and accelerate drug discovery. The Silicon Valley facility will bridge AI and lab science.

Unauthorized Drugs Seized from Vancouver Gym

Health Canada enforcement officers have seized unauthorized pharmaceutical drugs from a Vancouver fitness facility. Discover the details of the raid and the ongoing risks of unregulated substances.

FDA Approves Wegovy Weight Loss Pill

U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.

Fox Host Debunks Trump's 600% Drug Price Cut Claim

A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.

Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Pfizer 2026 profit forecast below expectations

Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.

China's Biopharma Surge Challenges Global Drug Leaders

China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Page 1 of 4